| C35 | HIV pre-exposure prophylaxis (PrEP) care in a LGBTQ community-based sexual health and wellness clinic after COVID-19 restrictions | E-poster | HIV prevention adaptations during COVID-19 |
| C34 | Evaluation of isoniazid preventive therapy received by children living with HIV in Nigeria | E-poster | Prevention for co-morbidities (e.g., TB, viral hepatitis) |
| C34 | Human Papilloma Virus (HPV) vaccination uptake in HIV patients: challenges during COVID-19 pandemic in Michigan, USA | E-poster | Prevention for co-morbidities (e.g., TB, viral hepatitis) |
| C34 | Integrating viral hepatitis and PrEP services through KP-led clinics in Vietnam: an opportunity to achieve dual elimination of HIV and viral hepatitis by 2030 | E-poster | Prevention for co-morbidities (e.g., TB, viral hepatitis) |
| C33 | The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across eleven distribution models in South Africa | On-demand oral abstract session | HIV self-testing |
| C33 | A successful launch of the first HIV self-testing pharmacy-based service demonstration project, Bangkok, Thailand | On-demand oral abstract session | HIV self-testing |
| C33 | User assessment of HIV self-testing (HIVST) in Brazil: an acceptable tool with great potential for reaching key populations and maximize positivity yield | On-demand oral abstract session | HIV self-testing |
| C33 | Feasibility of HIV self-testing among female sex workers in Iran: the SELFii study | On-demand oral abstract session | HIV self-testing |
| C33 | Reaching for the "first 95": a cross-country analysis of HIV self-testing in 177,572 people in nine countries in sub-Saharan Africa | On-demand oral abstract session | HIV self-testing |
| C33 | Effect of a regular self-testing kits distribution intervention on HIV testing and sexual-behavioral outcomes among MSM in China: a stepped-wedge randomized controlled trial | E-poster | HIV self-testing |